RYCCX
Price
$401.91
Change
+$11.83 (+3.03%)
Updated
Jun 24 closing price
Net Assets
1.14B
RYVLX
Price
$573.56
Change
+$16.88 (+3.03%)
Updated
Jun 24 closing price
Net Assets
1.14B
Interact to see
Advertisement

RYCCX vs RYVLX

Header iconRYCCX vs RYVLX Comparison
Open Charts RYCCX vs RYVLXBanner chart's image
Rydex NASDAQ-100® 2x Strategy C
Price$401.91
Change+$11.83 (+3.03%)
VolumeN/A
Net Assets1.14B
Rydex NASDAQ-100® 2x Strategy A
Price$573.56
Change+$16.88 (+3.03%)
VolumeN/A
Net Assets1.14B
RYCCX vs RYVLX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
RYCCX vs. RYVLX commentary
Jun 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYCCX is a Buy and RYVLX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RYCCX (1.14B) and RYVLX (1.14B) have equal amount of cash in the bank . RYCCX (0.00) and RYVLX (0.00) have matching dividends . RYCCX was incepted earlier than RYVLX: RYCCX (25 years) vs RYVLX (21 years). RYCCX (2.75) is less costly to investors than RYVLX (2.01). RYCCX (392.00) and RYVLX (392.00) have comparable annual turnover. RYCCX (2500) and RYVLX (2500) have matching initial minimum investment requirements. RYVLX annual gain was more profitable for investors over the last year : 5.84 vs. RYCCX (2.84). RYVLX return over 5 years is better than : 141.14 vs. RYCCX (116.80).
RYCCXRYVLXRYCCX / RYVLX
Total Expense Ratio2.651.90139%
Annual Report Gross Expense Ratio2.752.01137%
Fund Existence25 years21 years-
Gain YTD0.7521.11068%
Front LoadN/A5%-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets1.14B1.14B100%
Annual Yield % from dividends0.000.00-
Returns for 1 year2.845.8449%
Returns for 3 years115.34124.9692%
Returns for 5 years116.80141.1483%
Returns for 10 years479.56606.1679%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CCCC1.560.09
+6.12%
C4 Therapeutics
ARVN7.740.34
+4.59%
Arvinas
PPBI21.030.17
+0.81%
Pacific Premier Bancorp
APA18.18-0.21
-1.14%
APA Corp
XHG1.27-0.02
-1.40%
Xchange TEC Inc